These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 28763316)
61. Sugammadex antagonism of rocuronium-induced neuromuscular blockade in patients with liver cirrhosis undergoing liver resection: a randomized controlled study. Abdulatif M; Lotfy M; Mousa M; Afifi MH; Yassen K Minerva Anestesiol; 2018 Aug; 84(8):929-937. PubMed ID: 29405667 [TBL] [Abstract][Full Text] [Related]
62. Association between reversal agents (sugammadex vs. neostigmine) for neuromuscular block and postoperative pulmonary complications: A retrospective analysis. Ren A; Fan M; Gu Z; Liang X; Xu L; Liu C; Wang D; Chang H; Zhu M Br J Clin Pharmacol; 2024 Jul; 90(7):1667-1676. PubMed ID: 38583490 [TBL] [Abstract][Full Text] [Related]
63. Optimal dose of neostigmine antagonizing cisatracurium-induced shallow neuromuscular block in elderly patients: a randomized control study. Cao M; Huang H; Tong J; Ou Y; Liao Y BMC Anesthesiol; 2023 Aug; 23(1):269. PubMed ID: 37563623 [TBL] [Abstract][Full Text] [Related]
64. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium. Choi ES; Oh AY; Seo KS; Hwang JW; Ryu JH; Koo BW; Kim BG Anaesthesia; 2016 Apr; 71(4):443-9. PubMed ID: 26874258 [TBL] [Abstract][Full Text] [Related]
65. Reversal of vecuronium with neostigmine: a comparison between male and female patients. Saitoh Y; Aoki K; Okazaki M; Hirama T; Isosu T; Murakawa M Fukushima J Med Sci; 2009 Dec; 55(2):61-70. PubMed ID: 20608096 [TBL] [Abstract][Full Text] [Related]
66. Neostigmine Administration after Spontaneous Recovery to a Train-of-Four Ratio of 0.9 to 1.0: A Randomized Controlled Trial of the Effect on Neuromuscular and Clinical Recovery. Murphy GS; Szokol JW; Avram MJ; Greenberg SB; Shear TD; Deshur MA; Benson J; Newmark RL; Maher CE Anesthesiology; 2018 Jan; 128(1):27-37. PubMed ID: 28953501 [TBL] [Abstract][Full Text] [Related]
67. Residual neuromuscular blockade in a real life clinical setting: correlation with sugammadex or neostigmine administration. Batistaki C; Tentes P; Deligiannidi P; Karakosta A; Florou P; Kostopanagiotou G Minerva Anestesiol; 2016 May; 82(5):550-8. PubMed ID: 26394365 [TBL] [Abstract][Full Text] [Related]
68. Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial. Putz L; Dransart C; Jamart J; Marotta ML; Delnooz G; Dubois PE J Clin Anesth; 2016 Dec; 35():107-113. PubMed ID: 27871505 [TBL] [Abstract][Full Text] [Related]
69. Do we really need sugammadex as an antagonist of muscle relaxants in anesthesia? Meistelman C; Donati F Curr Opin Anaesthesiol; 2016 Aug; 29(4):462-7. PubMed ID: 27168088 [TBL] [Abstract][Full Text] [Related]
70. Recovery from mivacurium block with or without anticholinesterase following continuous infusion in obstetric patients. Jan GS; Tong WN; Chan AM; Hui TW; Lo JW Anaesth Intensive Care; 1996 Oct; 24(5):585-9. PubMed ID: 8909671 [TBL] [Abstract][Full Text] [Related]
71. Effects of magnesium sulphate on the pharmacodynamics of rocuronium in patients aged 60 years and older: A randomised trial. Rotava P; Cavalcanti IL; Barrucand L; Vane LA; Verçosa N Eur J Anaesthesiol; 2013 Oct; 30(10):599-604. PubMed ID: 23635996 [TBL] [Abstract][Full Text] [Related]
72. Residual neuromuscular blockade: management and impact on postoperative pulmonary outcome. Fuchs-Buder T; Nemes R; Schmartz D Curr Opin Anaesthesiol; 2016 Dec; 29(6):662-667. PubMed ID: 27755128 [TBL] [Abstract][Full Text] [Related]
73. The effect of sugammadex on steroid hormones: A randomized clinical study. Gunduz Gul G; Ozer AB; Demirel I; Aksu A; Erhan OL J Clin Anesth; 2016 Nov; 34():62-7. PubMed ID: 27687347 [TBL] [Abstract][Full Text] [Related]
74. Delayed reversal of a potentiated rocuronium neuromuscular block. Dubois PE Eur J Anaesthesiol; 2009 Apr; 26(4):350-2. PubMed ID: 19401670 [No Abstract] [Full Text] [Related]
75. Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block. Baurain MJ; Dernovoi BS; D'Hollander AA; Hennart DA; Cantraine FR Acta Anaesthesiol Scand; 1996 May; 40(5):574-8. PubMed ID: 8792887 [TBL] [Abstract][Full Text] [Related]
76. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine. Fuchs-Buder T; Meistelman C; Alla F; Grandjean A; Wuthrich Y; Donati F Anesthesiology; 2010 Jan; 112(1):34-40. PubMed ID: 19952724 [TBL] [Abstract][Full Text] [Related]
77. Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade. Kim KS; Oh YN; Kim TY; Oh SY; Sin YH Korean J Anesthesiol; 2016 Jun; 69(3):239-43. PubMed ID: 27274368 [TBL] [Abstract][Full Text] [Related]
78. Reversal of neuromuscular blockade with neostigmine has no effect on the incidence or severity of postoperative nausea and vomiting. Hovorka J; Korttila K; Nelskylä K; Soikkeli A; Sarvela J; Paatero H; Halonen P; Yli-Hankala A Anesth Analg; 1997 Dec; 85(6):1359-61. PubMed ID: 9390608 [TBL] [Abstract][Full Text] [Related]
79. Effects of magnesium sulphate on neostigmine-induced recovery from moderate neuromuscular blockade with rocuronium: a randomized controlled trial. Han J; Park HY; Shin HJ; Chung SH; Do SH Magnes Res; 2023 Jun; 36(2):31-39. PubMed ID: 37897256 [TBL] [Abstract][Full Text] [Related]
80. Residual paralysis: a real problem or did we invent a new disease? Donati F Can J Anaesth; 2013 Jul; 60(7):714-29. PubMed ID: 23625545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]